Holen Sie sich die Stockscreener-App
4.13
1.20%
-0.05
Handel nachbörslich:
4.15
0.02
+0.48%
Schlusskurs vom Vortag:
$4.18
Offen:
$4.18
24-Stunden-Volumen:
485.61K
Relative Volume:
0.68
Marktkapitalisierung:
$291.57M
Einnahmen:
$299.48M
Nettoeinkommen (Verlust:
$-86.45M
KGV:
-2.7533
EPS:
-1.5
Netto-Cashflow:
$-17.32M
1W Leistung:
-1.43%
1M Leistung:
+2.74%
6M Leistung:
-49.88%
1J Leistung:
-38.08%
1-Tages-Spanne:
$4.08
$4.32
1-Wochen-Bereich:
$3.80
$5.062
52-Wochen-Spanne:
$3.555
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Vergleichen Sie HCAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
4.13 | 291.57M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
237.05 | 38.54B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
59.19 | 11.13B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
61.37 | 9.87B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
90.40 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
40.01 | 7.04B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Health Catalyst, Inc. (NASDAQ:HCAT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
Health Catalyst (HCAT): Analyst Maintains Buy Rating, Lowers Price Target | HCAT Stock News - GuruFocus
Health Catalyst (HCAT) Target Price Raised by Stifel Analyst | HCAT Stock News - GuruFocus
Breaking Down Health Catalyst: 9 Analysts Share Their Views - Benzinga
Canaccord cuts Health Catalyst price target to $9, maintains buy By Investing.com - Investing.com Australia
Evercore ISI lifts Health Catalyst stock to $5 target By Investing.com - Investing.com Canada
Canaccord cuts Health Catalyst price target to $9, maintains buy - Investing.com
Canaccord Adjusts Price Target for Health Catalyst (HCAT), Remains Optimistic | HCAT Stock News - GuruFocus
Evercore ISI lifts Health Catalyst stock to $5 target - Investing.com
Detailed Analysis of Population Based Health Services Market | - openPR.com
Health Catalyst: Q1 Earnings Snapshot - MySA
Health Catalyst (HCAT) Surpasses Q1 Revenue and Earnings Projections | HCAT Stock News - GuruFocus
Health Catalyst Inc Reports Q1 2025 Earnings: EPS of -$0.35 Miss - GuruFocus
Earnings call transcript: Health Catalyst beats Q1 2025 EPS forecast, stock rises - Investing.com
Health Catalyst earnings beat, revenue topped estimates - Investing.com
Health Catalyst (NASDAQ:HCAT) Posts Q1 Sales In Line With Estimates, Stock Soars - Yahoo
Health Catalyst (HCAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Health Catalyst (HCAT) Q1 Earnings Meet Estimates - Yahoo Finance
Health Catalyst (HCAT) Projects FY25 Adjusted EBITDA of $41 Million | HCAT Stock News - GuruFocus
Health Catalyst Reports First Quarter 2025 Results - The Manila Times
Health Catalyst (HCAT) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
Health Catalyst Inc expected to post breakeven results a shareEarnings Preview - TradingView
Hims & Hers Health (HIMS) Stock Jumps 23.0%: Will It Continue to Soar? - Nasdaq
Health Catalyst Announces Strategic Partnership with Microsoft t - GuruFocus
Health Catalyst, Microsoft Collaborate to Accelerate AI Adoption in Healthcare - marketscreener.com
Health Catalyst (HCAT) Partners with Microsoft to Boost AI-Drive - GuruFocus
Health Catalyst Announces Strategic Partnership With Microsoft - marketscreener.com
Health Catalyst Announces Strategic Partnership with Microsoft to Accelerate AI Adoption and Transformation for Care Delivery Organizations - Longview News-Journal
Citi Adjusts Price Target for Health Catalyst (HCAT) Amid Earnin - GuruFocus
Q4 Earnings Outperformers: Health Catalyst (NASDAQ:HCAT) And The Rest Of The Data Analytics Stocks - Yahoo Finance
Cadence, DocuSign, Health Catalyst, UiPath, and Amplitude Shares Are Soaring, What You Need To Know - Yahoo Finance
Pure Storage, Health Catalyst, AMD, Micron, and FormFactor Stocks Trade Up, What You Need To Know - MSN
Patient Engagement Software Market Deep Research Report with - openPR.com
Best Statistical Healthcare Cognitive Analytics Market Growth - openPR.com
Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025 - The Manila Times
Healthcare Analytics Leader Health Catalyst Sets Q1 2025 Earnings Release Date - Stock Titan
Health Catalyst stock hits 52-week low at $3.56 amid market challenges By Investing.com - Investing.com South Africa
Health Catalyst stock hits 52-week low at $3.56 amid market challenges - Investing.com India
KeyBanc Adjusts Price Target for Health Catalyst (HCAT) Ahead of Q1 Earnings | HCAT Stock News - GuruFocus
Cantor Fitzgerald maintains overweight rating on Health Catalyst stock By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains overweight rating on Health Catalyst stock - Investing.com
Healthcare Data Analytics Market Is Booming Worldwide 2025-2032 | Health Catalyst, Oracle, Optum, SAS - openPR.com
HIMSSCast: "How do we grow again?" - Healthcare Finance News
Health Catalyst launches data and analytics solution for healthcare organisations - Yahoo
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.13%
0.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):